CLINICAL_TRIALS ClinicalTrials.gov record update

A Prospective, Open Label, Randomized Study to Evaluate Safety And Effectiveness Of The Tivoli® Biodegradable Polymer Rapamycin-Eluting Stent and The FIREBIRD2® Rapamycin-Eluting Coronary CoCr Stent For Treatment Coronary Revascularization

This page presents selected fields from the linked source record. It does not add a medical interpretation.

Record identity and dates

Source: ClinicalTrials.gov
Source record ID: NCT01681381
Title field or adapter rule: protocolSection.identificationModule.officialTitle
Ingested At: 2026-04-28T10:35:22.050821+00:00
Published At: 2013-02-21T00:00:00+00:00
Record Updated At: 2013-02-21
Timestamp Basis: source retrieval time was not retained by the feed adapter
Date limitation: source retrieval time was not retained by the feed adapter

protocolSection.conditionsModule.conditions: ["Ischemic Heart Disease", "Myocardial Ischemia", "Coronary Artery Lesions,Primary", "Coronary Disease", "Acute Coronary Syndrome", "Furcation Lesion of Coronary Artery"]
protocolSection.statusModule.lastUpdatePostDateStruct.date: "2013-02-21"
protocolSection.identificationModule.nctId: "NCT01681381"
protocolSection.identificationModule.officialTitle: "A Prospective, Open Label, Randomized Study to Evaluate Safety And Effectiveness Of The Tivoli\u00ae Biodegradable Polymer Rapamycin-Eluting Stent and The FIREBIRD2\u00ae Rapamycin-Eluting Coronary CoCr Stent For Treatment Coronary Revascularization"
protocolSection.statusModule.overallStatus: "UNKNOWN"
protocolSection.designModule.phases: ["NA"]
protocolSection.statusModule.resultsFirstPostDateStruct.date: ""

Intervention details are not present in the imported fields for this record. No drug-condition relationship is inferred from co-listing.

This index keeps the source fields it imported; it may not contain the complete original record. Verify wording and context in the linked source.